Open access · OA
via Europe PMC
Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis.
Zhong D, Hao C, Li M, Liu J, Xu Z, Zhou J, Zhao L, Ni S, Hu Z, Sun Y, Zou Y, Sun D, Guo H, Jia Z, Guo D
Aging cell · 2026
Abstract
Renal aging shortens healthspan(definition) and propagates organ dysfunction beyond the kidney, yet its molecular drivers remain incompletely defined. Here we identify microsomal prostaglandin E synthase-2 (mPGES-2) as a critical regulator of renal aging and its skeletal consequence. Genetic ablation of Ptges2 improved health indices in aged mice, prolonged median survival, and markedly alleviated glomerulosclerosis, podocyte injury, and renal senescence(definition). Single-cell transcriptomic analysis, together with podocyte- and tubule-specific knockout models, showed that podocyte mPGES-2, rather than tubular mPGES-2, is the dominant intrarenal driver of aging-related kidney injury. Mechanistically, mPGES-2 promoted podocyte senescence through a PGE<sub>2</sub>/EP1 signaling axis. Podocyte-specific Ptges2 deletion also mitigated age-related osteoporosis and restored renal calcitriol and α-klotho, supporting a kidney-bone mechanism secondary to impaired renal endocrine function. Consistent with the genetic models, pharmacological inhibition of mPGES-2 with SZ0232 attenuated renal aging and improved bone microarchitecture in aged mice. Both genetic deficiency and pharmacological inhibition of mPGES-2 were well tolerated, with no overt adverse effects on major organs. These findings identify podocyte mPGES-2 as a druggable determinant of renal aging and a potential therapeutic target for aging-associated osteoporosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1111/acel.70609
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
D, Z., C, H., M, L., J, L., Z, X., J, Z., L, Z., S, N., Z, H., Y, S., Y, Z., D, S., H, G., Z, J., D, G., JL, C., & Y., S. (2026). Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis. <em>Aging cell</em>. https://doi.org/10.1111/acel.70609
Vancouver
D Z, C H, M L, J L, Z X, J Z, et al. Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis. Aging cell. 2026. doi:10.1111/acel.70609.
BibTeX
@article{zhong2026Podocy,
title = {Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis.},
author = {Zhong D and Hao C and Li M and Liu J and Xu Z and Zhou J and Zhao L and Ni S and Hu Z and Sun Y and Zou Y and Sun D and Guo H and Jia Z and Guo D and Cao JL and Sun Y.},
journal = {Aging cell},
year = {2026},
doi = {10.1111/acel.70609},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 2018
Preprint · OA
Faculty Opinions recommendation of Role of dietary amino acid balance in diet restriction-mediated lifespan extension, renoprotection, and muscle weakness in aged mice.
Best Practice & Research Clinical Endocrinology & Metabolism 2008
Citation only
Epidemiology of osteoporosis
Trends in Endocrinology and Metabolism 1992
Citation only
Epidemiology of osteoporosis
Theranostics 2026
Open access · CC-BY
ARG2 drives osteoblast senescence by repressing mitophagy via the IκB–NF-κB–TXN2 signaling axis: implications for age-associated osteoporosis
Kobe University Repository Kernel (Kobe University) 1984
Preprint
Histomorphometric analysis of the mechanisms of bone loss : differentiation between physiological osteopenia in aging and postmenopausal osteoporosis as a disease
Aging Cell 2023
Open access · CC-BY